Lupin launches first ever Duloxetine 40mg Delayed-Release Capsules

Image
Capital Market
Last Updated : Sep 03 2015 | 8:01 PM IST

In the US

Lupin announced that its subsidiary, Lupin Pharmaceuticals Inc. has launched its Duloxetine 40 mg Delayed-Release (DR) capsules, which is the first and only generic Duloxetine formulation to become available in 40 mg dosage strength.

Lupin is the only generic manufacturer to offer Duloxetine dosage strengths - the 20 mg, 30 mg, 60 mg and now the newest 40 mg.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 03 2015 | 7:06 PM IST

Next Story